Nanotechnology Medicine Breakthroughs to Be Reported by Mayo Clinic Engineer

The Mayo Clinic College of Medicine in Rochester, Minnesota is sending Debabrata Mukhopadhyay, Professor of Biochemistry and Molecular Biology, and Biomedical Engineering, to report on his findings at nanoTX’07.

“The use of nanotechnology in biology has grown over recent years, incorporating the use of reagents such as nanoparticles to directly deliver bioconjugates or nanoparticles that can be utilized as biomolecules as well,” advance notes on Mukhopadhyay’s speech summary say. “Our research suggests that gold nanoparticles are antiangiogenic molecules, whereas some of the lanthanide nanorods are proangiogenic. Overall, our goal is to develop the next generation of nanomedicines that can be translated to the clinics in the near future.”

Mukhopadhyay will report how near that future is early on October 4 at the Dallas Convention Center.  All interested professionals can check the schedule and/or register at the web site, www.nanotx.biz